» Articles » PMID: 28780319

CDK1-mediated Mitotic Phosphorylation of PBK is Involved in Cytokinesis and Inhibits Its Oncogenic Activity

Overview
Journal Cell Signal
Date 2017 Aug 7
PMID 28780319
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

PDZ-binding kinase (PBK) plays a major role in proliferation and in safeguarding mitotic fidelity in cancer cells. Frequently upregulated in many cancers, PBK drives tumorigenesis and metastasis. PBK has been shown to be phosphorylated in mitosis by cyclin-dependent kinase 1 (CDK1)/cyclin B, however, no studies have been done examining PBK mitotic phosphorylation in oncogenesis. Additionally to the previously identified Threonine-9 phosphorylation, we found that Threonine-24, Serine-32, and Serine-59 of PBK are also phosphorylated. PBK is phosphorylated in vitro and in cells by CDK1 during antimitotic drug-induced mitotic arrest and in normal mitosis. We demonstrated that mitotic phosphorylation of Threonine-9 is involved in cytokinesis. The non-phosphorylatable mutant PBK-T9A augments tumorigenesis to a greater extent than wild type PBK in breast cancer cells, suggesting that PBK mitotic phosphorylation inhibits its tumor promoting activity. The PBK-T9A mutant also transforms and increases the proliferation of immortalized breast epithelial cells. Collectively, this study reveals that CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.

Citing Articles

miR-203-3p promotes senescence of mouse bone marrow mesenchymal stem cells via downregulation of Pbk.

Mei Q, Li K, Tang T, Cai S, Liu Y, Wang X Aging Cell. 2024; 23(11):e14293.

PMID: 39123275 PMC: 11561657. DOI: 10.1111/acel.14293.


PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.

Bordan Z, Batori R, Haigh S, Li X, Meadows M, Brown Z Circulation. 2024; 150(5):393-410.

PMID: 38682326 PMC: 11650665. DOI: 10.1161/CIRCULATIONAHA.123.067095.


Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent.

Chinyama H, Wei L, Mokgautsi N, Lawal B, Wu A, Huang H Int J Mol Sci. 2023; 24(22).

PMID: 38003585 PMC: 10671581. DOI: 10.3390/ijms242216396.


ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.

Xiao Y, Chen Y, Chen J, Dong J Cancers (Basel). 2023; 15(22).

PMID: 38001686 PMC: 10670399. DOI: 10.3390/cancers15225424.


Targeting CDK1 in cancer: mechanisms and implications.

Wang Q, Bode A, Zhang T NPJ Precis Oncol. 2023; 7(1):58.

PMID: 37311884 PMC: 10264400. DOI: 10.1038/s41698-023-00407-7.


References
1.
Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N . Characterization of a MAPKK-like protein kinase TOPK. Biochem Biophys Res Commun. 2004; 325(3):997-1004. DOI: 10.1016/j.bbrc.2004.10.133. View

2.
Jube S, Rivera Z, Bianchi M, Powers A, Wang E, Pagano I . Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res. 2012; 72(13):3290-301. PMC: 3389268. DOI: 10.1158/0008-5472.CAN-11-3481. View

3.
Wei D, Yeh Y, Hung J, Chou T, Wu Y, Lu P . Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. Cancer Sci. 2011; 103(4):731-8. PMC: 7659243. DOI: 10.1111/j.1349-7006.2011.02197.x. View

4.
Ran F, Hsu P, Wright J, Agarwala V, Scott D, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8(11):2281-2308. PMC: 3969860. DOI: 10.1038/nprot.2013.143. View

5.
Elcheva I, Brok-Volchanskaya V, Kumar A, Liu P, Lee J, Tong L . Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nat Commun. 2014; 5:4372. PMC: 4107340. DOI: 10.1038/ncomms5372. View